Gary Nieman Selected Research

Body Weight (Weight, Body)

3/2005

Rat cardiopulmonary bypass model: application of a miniature extracorporeal circuit composed of asanguinous prime.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gary Nieman Research Topics

Disease

11	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 04/2003
9	Lung Injury 01/2022 - 04/2003
9	Sepsis (Septicemia) 01/2015 - 02/2005
7	Inflammation (Inflammations) 01/2022 - 01/2012
7	Ventilator-Induced Lung Injury 12/2018 - 03/2005
5	Edema (Dropsy) 01/2022 - 08/2012
5	Pneumonia (Pneumonitis) 01/2022 - 09/2005
5	Acute Lung Injury 01/2022 - 03/2005
3	Wounds and Injuries (Trauma) 01/2022 - 01/2012
2	COVID-19 07/2022 - 01/2021
2	Hemorrhage 07/2022 - 01/2022
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 01/2015
2	Ischemia 01/2015 - 01/2013
2	Pulmonary Edema 08/2012 - 02/2005
2	Septic Shock (Toxic Shock Syndrome) 01/2007 - 10/2005
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 09/2005 - 12/2002
1	Emphysema 01/2022
1	Pulmonary Arterial Hypertension 01/2022
1	Bacterial Pneumonia 04/2016
1	Critical Illness (Critically Ill) 04/2015
1	Acute Kidney Injury (Acute Renal Failure) 01/2015
1	Acidosis 01/2015
1	Multiple Organ Failure (MODS) 11/2012
1	Reperfusion Injury 10/2005
1	Thrombosis (Thrombus) 10/2005
1	Body Weight (Weight, Body) 03/2005
1	Bacteremia 02/2005
1	Clinical Deterioration 02/2005

Drug/Important Bio-Agent (IBA)

4	Surface-Active Agents (Surfactants)IBA 11/2013 - 04/2003
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2015
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2015
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 10/2005
3	CytokinesIBA 01/2021 - 02/2005
3	Tetracycline (Achromycin)FDA LinkGeneric 01/2015 - 10/2005
3	tetracycline CMT-3IBA 01/2015 - 10/2005
2	AmphiregulinIBA 01/2022 - 01/2018
2	LipopolysaccharidesIBA 01/2022 - 01/2018
2	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2022 - 10/2005
1	AnticoagulantsIBA 07/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2022
1	Pancreatic Elastase (Elastase)IBA 01/2022
1	InflammasomesIBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	Smart MaterialsIBA 01/2022
1	Caspase 1 (ICE Protease)IBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	progelatinaseIBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2018
1	SyndecansIBA 01/2018
1	CollagenIBA 01/2018
1	DecorinIBA 01/2018
1	1,7- bis(4- hydroxyphenyl)- 4- N- phenylaminocarbonylhepta- 1,6- dien- 3,5- dioneIBA 04/2016
1	CurcuminIBA 04/2016
1	Polysorbates (PSML)FDA Link 11/2014
1	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 01/2013
1	GasesIBA 01/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2013
1	Cadherins (E-Cadherin)IBA 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2012
1	AlarminsIBA 01/2012
1	drotrecogin alfa activated (Xigris)FDA Link 12/2011
1	Peptide Hydrolases (Proteases)FDA Link 10/2005
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 02/2005

Therapy/Procedure

13	Artificial Respiration (Mechanical Ventilation) 07/2022 - 04/2003
8	Continuous Positive Airway Pressure 01/2021 - 01/2013
5	Therapeutics 01/2013 - 12/2011
3	Critical Care (Surgical Intensive Care) 07/2022 - 02/2005
3	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2021 - 01/2007
3	Mechanical Ventilators (Ventilator) 11/2014 - 02/2006
2	Length of Stay 07/2022 - 04/2015
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 09/2005 - 12/2002
1	Anesthesia 08/2012
1	Laparotomy 10/2005
1	Oxygenators 03/2005